ArticleMedicine, health care, and philosophy2026
Choosing how to decide: empowering patients for shared decision-making in end-of-life care.
Article in Medicine, health care, and philosophy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Shared Decision-Making (SDM) is a process wherein patients and clinicians make healthcare decisions collaboratively. There are two main versions of SDM. The first is narrow SDM, wherein the clinician's role is limited to things like providing information and eliciting (without challenging) the patient's preferences. The second is broad SDM, wherein the clinician participates in the decision-making in various additional ways (e.g., by providing recommendations). In this paper, I argue that there are cases where a patient would not be wronged by a clinician letting them choose from a range of versions of SDM - including narrow SDM and types of broad SDM - for an end-of-life treatment decision. This paper's structure is as follows. First, I explain my proposal. Second, I provide a brief rationale for it. Third, I thoroughly defend it from the likeliest objection, which holds that clinicians in the relevant cases should offer only narrow SDM because broad SDM would unduly influence patients. This paper's originality comes from (i) presenting a new and uniquely detailed proposal for when and how to offer versions of SDM and (ii) exploring the ethical implications of a patient's choice of a version, understood as an act of consent. The main purpose of my proposal's many details is to maximize how much the SDM would advance patient autonomy (and, secondarily, patient wellbeing).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.